scholarly article | Q13442814 |
P50 | author | Nestor F Gonzalez-Cadavid | Q92730697 |
Jorge N. Artaza | Q122229070 | ||
Con Mallidis | Q42531539 | ||
Shalender Bhasin | Q64495451 | ||
P2093 | author name string | Kun Ma | |
Behrouz Salehian | |||
Jose Arias | |||
Vahid Mahabadi | |||
P2860 | cites work | Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting | Q22008491 |
Regulation of myostatin activity and muscle growth | Q24555817 | ||
Double muscling in cattle due to mutations in the myostatin gene | Q24648136 | ||
Myostatin and the control of skeletal muscle mass | Q28145470 | ||
Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1 | Q28204465 | ||
Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy | Q28245961 | ||
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle | Q28250102 | ||
Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist | Q28336948 | ||
Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver | Q28365905 | ||
C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle | Q28565301 | ||
Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight | Q28577604 | ||
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells | Q31833462 | ||
Glucocorticoids and muscle catabolism | Q33716942 | ||
Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease | Q34074665 | ||
Control of muscle development by dueling HATs and HDACs | Q34088887 | ||
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle | Q34438337 | ||
Molecular regulation of muscle cachexia: it may be more than the proteasome | Q34485774 | ||
Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids | Q34529658 | ||
Control of muscle protein breakdown: effects of activity and nutritional states | Q34577967 | ||
Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging | Q35765499 | ||
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids | Q37350232 | ||
Myostatin is an inhibitor of myogenic differentiation. | Q40739514 | ||
Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells | Q40755294 | ||
Myostatin regulates cell survival during C2C12 myogenesis | Q40829857 | ||
Transcription factors and asthma | Q40846857 | ||
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway | Q41249327 | ||
Effect of corticosterone administration at varying levels on leucine oxidation and whole body protein synthesis and breakdown in adrenalectomized rats | Q42053038 | ||
Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro | Q44226350 | ||
Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. | Q45940714 | ||
Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hind-limb muscles | Q49067804 | ||
Effects of glucocorticoid treatment and food restriction on rat hindlimb muscles | Q49162383 | ||
P433 | issue | 2 | |
P304 | page(s) | E363-71 | |
P577 | publication date | 2003-04-29 | |
P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
P1476 | title | Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression | |
P478 | volume | 285 |
Q37218921 | A Role for Myokines in Muscle-Bone Interactions |
Q35993669 | A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. |
Q46513116 | A comparative examination of cortisol effects on muscle myostatin and HSP90 gene expression in salmonids. |
Q44523986 | A membrane glucocorticoid receptor mediates the rapid/non-genomic actions of glucocorticoids in mammalian skeletal muscle fibres. |
Q34785536 | A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice |
Q30496704 | Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy |
Q35622374 | Age-related changes in thirst, salt appetite, and arterial blood pressure in response to aldosterone-dexamethasone combination in rats |
Q90295069 | Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy |
Q37546849 | An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy |
Q42465386 | An evolutionarily conserved Myostatin proximal promoter/enhancer confers basal levels of transcription and spatial specificity in vivo. |
Q46657318 | An unusual lipomatous brain mass in a Golden Retriever dog. |
Q24795157 | Antiglucocorticoid RU38486 reduces net protein catabolism in experimental acute renal failure |
Q48514411 | Blocking extracellular activation of myostatin as a strategy for treating muscle wasting |
Q34429152 | CCAAT/enhancer binding protein-δ expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro |
Q36648792 | Cancer cachexia: it's time for more clinical trials |
Q40987037 | Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia |
Q42250061 | Cardiac and vascular atrogin-1 mRNA expression is not associated with dexamethasone efficacy in the monocrotaline model of pulmonary hypertension |
Q26744140 | Cardiac cachexia: hic et nunc |
Q35683683 | Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race |
Q38338967 | Chicken ovalbumin upstream promoter-transcription factor II regulates nuclear receptor, myogenic, and metabolic gene expression in skeletal muscle cells. |
Q36861023 | Clinical, agricultural, and evolutionary biology of myostatin: a comparative review |
Q37270488 | Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide |
Q98944959 | Development of muscle atrophy and loss of function in a Gulf-War illness model: underlying mechanisms |
Q46538025 | Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus |
Q35667262 | Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats |
Q51681547 | Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy. |
Q43252739 | Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice |
Q51362680 | Effect of active immunization against a recombinant mouse granulocyte-macrophage colony-stimulating factor/somatostatin fusion protein on the growth of mice. |
Q43239281 | Effect of dietary probiotics on clownfish: a molecular approach to define how lactic acid bacteria modulate development in a marine fish |
Q34489678 | Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy |
Q37609256 | Effects of concentric and eccentric muscle actions on serum myostatin and follistatin-like related gene levels |
Q83812471 | Effects of pre-exercise feeding on serum hormone concentrations and biomarkers of myostatin and ubiquitin proteasome pathway activity |
Q84712742 | Effects of transforming growth factor-beta (TGF-β1) on satellite cell activation and survival during oxidative stress |
Q37791182 | Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms |
Q35083601 | Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality |
Q41658783 | Embryonic and tissue-specific regulation of myostatin-1 and -2 gene expression in zebrafish |
Q37389085 | Estradiol in females may negate skeletal muscle myostatin mRNA expression and serum myostatin propeptide levels after eccentric muscle contractions |
Q46932793 | Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats |
Q43228354 | Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment |
Q49681521 | Expression of diaphragmatic myostatin and correlation with apoptosis in rats with chronic obstructive pulmonary disease |
Q43286525 | Expression of genes related to myostatin signaling during rat skeletal muscle longitudinal growth |
Q82437478 | Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection |
Q40239056 | Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury |
Q44266626 | Expression profiling of skeletal muscle in young bulls treated with steroidal growth promoters. |
Q91580018 | G protein-coupled receptor kinase 2 regulates mitochondrial bioenergetics and impairs myostatin-mediated autophagy in muscle cells |
Q37250460 | Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease |
Q80796644 | Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice |
Q64927268 | Glucocorticoid-induced CREB activation and myostatin expression in C2C12 myotubes involves phosphodiesterase-3/4 signaling. |
Q35135088 | Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism |
Q36030304 | Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage |
Q91916997 | Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle |
Q34067618 | Glucocorticoids increase salt appetite by promoting water and sodium excretion |
Q39681574 | Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-α. |
Q44970167 | Growth hormone differentially regulates muscle myostatin1 and -2 and increases circulating cortisol in rainbow trout (Oncorhynchus mykiss). |
Q38739971 | Heat Stress Modulates Both Anabolic and Catabolic Signaling Pathways Preventing Dexamethasone-Induced Muscle Atrophy In Vitro |
Q42747919 | Histomorphometric changes in the perirenal adipocytes of adrenalectomized rats treated with dexamethasone |
Q36665191 | Hormonal receptors in skeletal muscles of dystrophic mdx mice |
Q57300292 | Hypoglycemic Properties of the Aqueous Extract from the Stem Bark of in Dexamethasone-Induced Insulin Resistant Rats |
Q39919378 | Hypothyroidism is associated with increased myostatin expression in rats. |
Q51820504 | Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. |
Q34586285 | Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit |
Q38017953 | Implications of glucocorticoid therapy in idiopathic inflammatory myopathies |
Q35536351 | Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia |
Q36001532 | Interaction between muscle and bone, and improving the effects of electrical muscle stimulation on amyotrophy and bone loss in a denervation rat model via sciatic neurectomy |
Q38617041 | Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb Girdle Muscular Dystrophy |
Q39714216 | L6E9 myoblasts are deficient of myostatin and additional TGF-beta members are candidates to developmentally control their fiber formation. |
Q34429462 | Lactobacillus rhamnosus accelerates zebrafish backbone calcification and gonadal differentiation through effects on the GnRH and IGF systems |
Q35086825 | Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women |
Q47936364 | Linkage of myostatin pathway genes with knee strength in humans |
Q85358877 | Low-protein diet fed to crossbred sows during pregnancy and lactation enhances myostatin gene expression through epigenetic regulation in skeletal muscle of weaning piglets |
Q44489665 | Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin |
Q34447001 | METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. |
Q42485411 | Maintenance of the spinal nucleus of the bulbocavernosus neuromuscular system is not influenced by physiological levels of glucocorticoids |
Q38890362 | Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres |
Q38092488 | Metabolic functions of glucocorticoid receptor in skeletal muscle |
Q38207093 | Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues |
Q33349016 | Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy |
Q50900869 | Molecular characterization of myostatin from the skeletal muscle of the African lungfish, Protopterus annectens, and changes in its mRNA and protein expression levels during three phases of aestivation. |
Q38353108 | Morphological and biochemical alterations of skeletal muscles from the genetically obese (ob/ob) mouse |
Q35939993 | Muscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease |
Q51188121 | Muscle wasting in collagen-induced arthritis and disuse atrophy. |
Q36647399 | Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy. |
Q54450832 | Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure. |
Q42994266 | Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice |
Q37635807 | Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake |
Q36515547 | Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects |
Q34629780 | Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction. |
Q38292770 | Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice |
Q26797484 | Myostatin: expanding horizons |
Q36687329 | Neck muscle cross-sectional area, brain volume and cognition in healthy older men: a cohort study. |
Q35855917 | Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation |
Q33544449 | Normalizing RT-qPCR data: are we getting the right answers? An appraisal of normalization approaches and internal reference genes from a case study in the finfish Lates calcarifer |
Q34378165 | Pathological fractures in paediatric patients with inflammatory bowel disease |
Q90704987 | Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience |
Q42011965 | Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy |
Q48120255 | Phylogenetic analysis of the myostatin gene sub-family and the differential expression of a novel member in zebrafish |
Q55053966 | Physiological elevation of endogenous hormones results in superior strength training adaptation. |
Q36881964 | Plasticity of human skeletal muscle: gene expression to in vivo function. |
Q34501675 | Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle |
Q26996234 | Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation |
Q41898403 | Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization |
Q51309321 | Quantitative and qualitative adaptations of muscle fibers to glucocorticoids. |
Q64238830 | Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice |
Q28564515 | Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats |
Q38135640 | Revisiting the paradigm of myostatin in vertebrates: insights from fishes |
Q64988797 | Rheumatoid arthritis in remission : Decreased myostatin and increased serum levels of periostin. |
Q35166254 | Role of TGF-β signaling in inherited and acquired myopathies |
Q26825916 | Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds |
Q33925571 | Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice |
Q42949695 | Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle |
Q45329196 | Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. |
Q64891195 | Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone. |
Q37890215 | Steroid myopathy: some unresolved issues. |
Q54572065 | Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. |
Q34771160 | Systematic review: body composition in adults with inflammatory bowel disease |
Q43095052 | TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice. |
Q38982057 | TRAF6 inhibition rescues dexamethasone-induced muscle atrophy |
Q41825244 | Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases. |
Q35739702 | Targeting the myostatin signaling pathway to treat muscle wasting diseases |
Q42726736 | Testosterone reduced methylprednisolone-induced muscle atrophy in spinal cord-injured rats |
Q22242626 | The aetiology and impact of malnutrition in paediatric inflammatory bowel disease |
Q33864678 | The effects of exogenous cortisol on myostatin transcription in rainbow trout, Oncorhynchus mykiss |
Q37713606 | The function of myostatin in the regulation of fat mass in mammals |
Q28592692 | The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy |
Q36607060 | The molecular mechanisms of skeletal muscle wasting: implications for therapy. |
Q49034737 | The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease |
Q37103765 | The pituitary-adrenal axis and body composition |
Q92401998 | The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1 |
Q33910776 | Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration |
Q28569232 | Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats |
Q40177102 | Transcriptional pathways associated with skeletal muscle disuse atrophy in humans |
Q56171520 | Welfare improvement using alginic acid in rainbow trout (Oncorhynchus mykiss) juveniles |
Q34004260 | Whole body cortisol and expression of HSP70, IGF-I and MSTN in early development of sea bass subjected to heat shock |
Q44682872 | mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass |
Search more.